当前位置:首页 - 行情中心 - 国药现代(600420) - 财务分析 - 现金流量表

国药现代

(600420)

  

流通市值:124.19亿  总市值:124.19亿
流通股本:13.41亿   总股本:13.41亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,433,187,760.119,367,460,124.446,556,114,497.374,304,724,164.42
  收到的税费返还7,719,458.6842,838,500.1842,833,163.3939,127,684.33
  收到其他与经营活动有关的现金23,289,452.96189,428,213.28122,304,154.7584,157,633.56
  经营活动现金流入小计1,464,196,671.759,599,726,837.96,721,251,815.514,428,009,482.31
  购买商品、接受劳务支付的现金1,085,520,820.394,130,391,864.22,858,346,117.61,839,667,959.45
  支付给职工以及为职工支付的现金399,454,809.781,817,672,846.111,244,115,288.26854,671,562.41
  支付的各项税费153,833,077.22650,850,023.38509,896,460.46380,324,938.54
  支付其他与经营活动有关的现金188,701,903.931,302,723,050.88967,264,214.08685,364,756.01
  经营活动现金流出小计1,827,510,611.327,901,637,784.575,579,622,080.43,760,029,216.41
  经营活动产生的现金流量净额-363,313,939.571,698,089,053.331,141,629,735.11667,980,265.9
二、投资活动产生的现金流量:
  收回投资收到的现金-3,030,562.96284,276.73284,276.73
  取得投资收益收到的现金23,570,739.8438,545,130.7224,526,859.4112,140,416.68
  处置固定资产、无形资产和其他长期资产收回的现金净额6006,153,234.93,268,112.461,792,958.86
  处置子公司及其他营业单位收到的现金净额-102,598,445.98--
  收到的其他与投资活动有关的现金1,965,610,416.674,484,682,991.483,381,348,2502,416,000,000
  投资活动现金流入小计1,989,181,756.514,635,010,366.043,409,427,498.62,430,217,652.27
  购建固定资产、无形资产和其他长期资产支付的现金56,656,829.03263,826,239.02206,804,927.07139,697,905.48
  支付其他与投资活动有关的现金1,883,640,0006,762,794,6254,877,422,1253,386,000,000
  投资活动现金流出小计1,940,296,829.037,026,620,864.025,084,227,052.073,525,697,905.48
  投资活动产生的现金流量净额48,884,927.48-2,391,610,497.98-1,674,799,553.47-1,095,480,253.21
三、筹资活动产生的现金流量:
  收到其他与筹资活动有关的现金-40,000,000--
  筹资活动现金流入平衡项目-0--
  筹资活动现金流入小计-40,000,000--
  偿还债务支付的现金-1,050,000,0001,050,000,0001,020,000,000
  分配股利、利润或偿付利息支付的现金-512,929,759.63475,452,502.0360,332,219.65
  其中:子公司支付给少数股东的股利、利润-85,034,359.7744,755,390.2244,755,390.22
  支付其他与筹资活动有关的现金5,273,823.32119,513,377.43115,519,644.07116,340,294.07
  筹资活动现金流出小计5,273,823.321,682,443,137.061,640,972,146.11,196,672,513.72
  筹资活动产生的现金流量净额-5,273,823.32-1,642,443,137.06-1,640,972,146.1-1,196,672,513.72
四、汇率变动对现金及现金等价物的影响-6,150,170.8615,344,679.2418,636,588.3820,317,200.65
五、现金及现金等价物净增加额-325,853,006.27-2,320,619,902.47-2,155,505,376.08-1,603,855,300.38
  加:期初现金及现金等价物余额3,824,394,182.046,145,014,084.516,145,014,084.516,145,014,084.51
  期末现金及现金等价物余额3,498,541,175.773,824,394,182.043,989,508,708.434,541,158,784.13
补充资料:
  净利润-1,142,165,623.26-770,180,065.38
  资产减值准备-124,085,889.98-38,676,688.82
  固定资产和投资性房地产折旧-650,006,984.66-315,753,610.53
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-650,006,984.66-315,753,610.53
  无形资产摊销-66,898,259.37-28,446,922.5
  长期待摊费用摊销-6,622,737.91-4,540,050.16
  处置固定资产、无形资产和其他长期资产的损失-2,651,461.17-65,422.93
  固定资产报废损失-1,160,836.96-844,180.63
  财务费用-4,385,554-2,843,148.12
  投资损失--133,898,891.94--41,030,017.72
  递延所得税--20,958,263.12-2,299,567.74
  其中:递延所得税资产减少--12,679,006.77-2,113,648.13
    递延所得税负债增加--8,279,256.35-185,919.61
  存货的减少-485,711,359.68-101,472,412.01
  经营性应收项目的减少-187,082,125.3--363,051,432.4
  经营性应付项目的增加--833,490,187.71--220,489,370.71
  现金的期末余额-3,824,394,182.04-4,541,158,784.13
  减:现金的期初余额-6,145,014,084.51-6,145,014,084.51
  现金及现金等价物的净增加额--2,320,619,902.47--1,603,855,300.38
公告日期2026-04-302026-03-282025-10-302025-08-30
审计意见(境内)标准无保留意见
TOP↑